BioAutism Ltd is pleased to announce the award of its inaugural research grant to Dr Wah Chin Boon at The Florey Institute of Neuroscience and Mental Health.

Dr Boon will be investigating the in utero effects of endocrine disruptors in autism using a mouse model. More specifically, she will be examining whether in utero exposure to diethylhexylphthalate (DEHP) at FDA approved levels will result in autistic like behaviour and brain phenotype in mouse offspring. (Attach photo with names of people as follows" L-R Dennis Crowley CEO BioAutism Ltd, Dr Wah Chin Boon, Prof Geoffrey Donnan AO, Director of The Florey Institute of Neuroscience and Mental Health, Robert Klupacs, Director BioAutism Ltd)